Meyer-Rienecker H, Jenssen H L, Köhler H, Günther J K
Dtsch Med Wochenschr. 1975 Mar 14;100(11):538-43. doi: 10.1055/s-0028-1106252.
The macrophage-electrophoretic-mobility (MEM) tests of Field and Caspary demonstrates the macrophage-slowing factor (MSF) produced by specifically sentised blood lymphocytes after incubation with the homologous antigen. Besides other diseases with a cellular immune reaction like multiple sclerosis malignant tumours show a reduction of the macrophage mobility in the cell electrophoresis. A significant inhibition in the MEM- test was found in 30 out of 33 tumours of the CNS. Glioblastomas, astrocytomas, spongioblastomas, ependymomas, neurinomas, meningiomas, and a myxofibroma showed a positive result (more than 10% inhibition). The results in ectodermal tumours (pituitary adenoma, craniopharyngioma) differed; secondary brain tumours showed the greatest inhibition.
菲尔德和卡斯帕里的巨噬细胞电泳迁移率(MEM)试验表明,经同源抗原孵育后,特异性致敏血淋巴细胞可产生巨噬细胞趋缓因子(MSF)。除了多发性硬化症等其他具有细胞免疫反应的疾病外,恶性肿瘤在细胞电泳中也显示巨噬细胞迁移率降低。在33例中枢神经系统肿瘤中,有30例在MEM试验中发现有显著抑制作用。胶质母细胞瘤、星形细胞瘤、成胶质细胞瘤、室管膜瘤、神经鞘瘤、脑膜瘤和黏液纤维瘤呈阳性结果(抑制率超过10%)。外胚层肿瘤(垂体腺瘤、颅咽管瘤)的结果有所不同;继发性脑肿瘤的抑制作用最大。